In China, there are 330 million patients with cardiovascular disease which accounts for the first cause of all deaths. Among these cardiovascular diseases, chronic heart failure is often irreversible and difficult to control, while acute heart failure is severe and requires immediate treatment once diagnosed.
Ventricular Assist Device (so-called artificial hearts) are to maintain blood circulation and body function when the patient's heart is temporarily unable to work due to various acute reasons, which provide time for the patient's heart to recover or have transition to other treatments. Once the patient's physical condition was stable, the device was removed immediately.
In the past, the development of ventricular assist devices was mostly dominated by Western countries. magAssist has committed to delivering the most renowned life saving technology and science for our patients and clinicians ever since its development. It is our utmost desire to collaborate with professionals and make an influence on improving the medical device industry. Our current ventricular assist device product in development includes an extracorporeal ventricular assist device and interventional ventricular assist device.